February 13, 2026 · Form 4 insider transaction
Viehbacher Christopher bought 38,015 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.